Brief

"On February 01, 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) issued an update regarding New MHRA Chair Anthony Harnden outlines priorities as he starts role. In his first 100 days, Anthony prioritizes talking and listening to staff and partner organizations to drive forward the strategic direction of the MHRA, focusing on patient safety, risk-proportionate regulation, and an inclusive workplace. With 33 years of experience working with patients as a general practitioner, Anthony aims to maintain the UK's global centre of excellence in life sciences."

This content is restricted.

Highlights content goes here...

This content is restricted.

Medicines and Healthcare products Regulatory Agency (MHRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies